Natchez Morice, MD, Mba, LLC
Natchez Morice, MD, Mba, LLC was paid $3.13M by Medicaid between Jan 2018 and Jul 2024, across 72 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 16% of everything it billed.
33Billing provider infoNATCHEZ MORICE, MD, MBA, LLC
MORGAN CITY, LA 70380
MORGAN CITY, LA 70380
33aNPI1477850485assigned 02/28/2011
33bProvider typeSpecialist
28Total paid$3.13M
24GClaims124,904
24DCodes billed72
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Specialist providers in Louisiana
Rank by total paid#16 of 228
Median peer was paid$60K
This provider vs. median52×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,395 | $494K | |
| 2019 | 20,585 | $521K | |
| 2020 | 26,889 | $588K | |
| 2021 | 18,923 | $606K | |
| 2022 | 16,915 | $543K | |
| 2023 | 18,943 | $378K | |
| 2024incomplete | 254 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 9,308 | 5,996 | $501K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.6% | 8,738 | 6,554 | $302K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.0% | 9,048 | 6,880 | $249K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.9% | 9,021 | 6,869 | $248K |
| 76819 | Fetal biophysical profile; without non-stress testing | 6.8% | 3,641 | 1,481 | $214K |
| 76830 | Ultrasound, transvaginal | 6.6% | 3,590 | 2,879 | $205K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.6% | 4,093 | 2,522 | $176K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.4% | 1,978 | 1,545 | $137K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4.3% | 5,139 | 4,041 | $136K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.9% | 1,372 | 1,160 | $91K |
| 81513 | 2.9% | 995 | 863 | $90K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.6% | 1,582 | 1,312 | $82K |
60 more codes
| 80050 | General health panel | 2.2% | 2,996 | $69K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.1% | 2,763 | $64K |
| 81025 | 2.0% | 13,184 | $64K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.0% | 1,208 | $62K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 1,865 | $42K |
| 84481 | <1% | 4,098 | $28K | |
| 84144 | <1% | 1,786 | $26K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,268 | $25K |
| 82670 | <1% | 1,139 | $22K | |
| 87905 | <1% | 2,118 | $21K | |
| 84403 | <1% | 1,201 | $20K | |
| 87808 | <1% | 1,863 | $19K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 441 | $19K |
| 83525 | <1% | 2,022 | $16K | |
| 83735 | <1% | 3,384 | $16K | |
| 84439 | <1% | 2,669 | $15K | |
| 84702 | <1% | 1,463 | $14K | |
| 83001 | <1% | 1,222 | $14K | |
| 84270 | <1% | 941 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,889 | $14K |
| 83002 | <1% | 1,131 | $13K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,918 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,719 | $13K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 173 | $13K |
| 82627 | <1% | 575 | $8K | |
| 80061 | Lipid panel | <1% | 1,034 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 553 | $7K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 158 | $6K |
| 87210 | <1% | 1,723 | $6K | |
| 82120 | <1% | 1,757 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 80 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 65 | $4K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 76 | $3K |
| H0049 | Alcohol and/or drug screening | <1% | 305 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 21 | $2K |
| 80305 | <1% | 163 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 166 | $1K |
| 81002 | <1% | 824 | $1K | |
| 83986 | <1% | 365 | $1K | |
| 87625 | <1% | 29 | $752.22 | |
| 82962 | <1% | 362 | $627.04 | |
| 83021 | <1% | 31 | $433.44 | |
| 90686 | <1% | 29 | $418.66 | |
| 80074 | <1% | 120 | $381.04 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 29 | $352.80 |
| 86803 | <1% | 62 | $315.65 | |
| 86762 | <1% | 53 | $266.39 | |
| 86850 | <1% | 129 | $213.61 | |
| 86709 | <1% | 63 | $210.63 | |
| 86787 | <1% | 55 | $207.46 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 81 | $200.75 |
| 87340 | <1% | 61 | $197.51 | |
| 84146 | <1% | 107 | $192.80 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 89 | $159.24 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 157 | $96.60 |
| 86592 | <1% | 121 | $59.86 | |
| 81003 | <1% | 45 | $46.68 | |
| 84480 | <1% | 416 | $12.76 | |
| 86900 | <1% | 21 | $11.92 | |
| 99000 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORICE, NATCHEZ (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Atchafalaya Gynecoloogy and Obstetrics | Morgan City, LA | $1.65M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.